The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
Transient Neurologic and Ocular Manifestations in Primary Thrombocythemia
Neurol 43:1107-1110, Michiels,J.J.,et al, 1993
Does Low-Dose ASA Prevent Stroke After Carotid Surgery? A Double-blind, Placebo-controlled Randomized Trial
Stroke 24:1125-1128, Lindblad,B.,et al, 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Safety of Anticoagulation After Hemorrhagic Infarction
Neurol 43:1298-1303, Pessin,M.S.,et al, 1993
Coagulation Abnormalities and Cerebral Infarction
JNNP 56:433-439, Greaves,M., 1993
Complications of Therapy for Venous Thromboembolic Disease in Patients with Brain Tumors
Neurol 43:1111-1114, Levin,J.M.,et al, 1993
The Antiphospholipid Syndrome:Ten years On
Lancet 342:341-344, Hughes,G.R.V., 1993
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993
Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993
Deep Cerebral Venous System Thrombosis:Case Report
Neurosurgery 33:911-913, Brown,J.I.M.,et al, 1993
Efficacy of Ticlopidine & Aspirin for Prev of Rev Cerebrovascular Ischemic Events, Ticlopidine Aspirin Study
Stroke 24:1452-1457, Bellavance,A.,et al, 1993
Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992
Anticoagulant Treatment as a Risk Factor for Primary Intracerebral Hemorrhage
JNNP 55:1121-1124, Fogelholm,R.,et al, 1992
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992
Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992
Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992
Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992
Cerebromeningeal Haemophagocytic Lymphohistiocytosis
Lancet 239:104-107, Henter,J.&Elinder,G., 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Emergency Reversal of Anticoagulation aftr Intracerebral Hemorrhage
Stroke 23:972-977, Fredriksson,K.,et al, 1992
Wilson Disease
Medicine 71:139-164, Brewer,G.J.&Yuzbasiyan-Gurkan,V., 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Antiphospholipid Antibody Syndrome
JAMA 268:1451-1453, Lockshin,M.D., 1992
Pharmacologic Treatment of Childhood Migraine
J Pediatr 120:653-657, Ingarashi,M.,et al, 1992
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
Arch Int Med 152:278-282, 2571992., Bussey,H.I.,et al, 1992
Cerebral Venous Thrombosis in Behcet's Disease:Clinical Study and Long-Term Follow-Up of 25 Cases
Neurol 42:614-618, Wechsler,B.,et al, 1992
Neurodevelopmental Outcome of Term Infants with Intraventricular Hemorrhage
Am J Dis Child 146:194-197, Jocelyn,L.J.&Casiro,O.G., 1992
Acute Compartment Syndromes Resulting from Anticoagulant Treatment
BMJ 305:1474-1475, Hay,S.M.,et al, 1992
Risk FActors for Central Nervous System Manifest of Gastroenteritis-Associated Hemolytic-Uremic Syndrome
Pediatrics 90:616-621, Cimolai,N.,et al, 1992
Venous Thromboembolism in Stroke:Literature Review and Implications for Clinical Practice
Arch Phys Med Rehabil 73:379-391, Brandstater,M.E.,et al, 1992
Role of Prophyl Anticoag for Direct Current Cardiover in Pts with Atrial Fib, Atrial Flutter
J Am Coll Cardiol 19:851-855, Zeiler,A.,et al, 1992
Adult Reye's Syndrome:A Review with New Evidence for a Generalized Defect in Intramitochondrial Enzyme Processing
Neurol 41:1815-1821, VanCoster,R.N.,et al, 1991
NEurologic Complications of Nonneuronopathic Gaucher's Disease
Arch Neurol 48:1271-1272, Grewal,R.P.,et al, 1991
Erythromelalgia:Review of Clinical Characteristics and Pathophysiology
Am J Med 91:416-422, Jurzrock,R.&Cohen,P.R., 1991
Central Nervous System Infarction Related to Cocaine Abuse
Stroke 22:1320-1325, Daras,M.,et al, 1991
Wilson Disease:Clinical Presentation, Treatment, and Survival
Ann Int Med 115:720-726, Stremmel,W.,et al, 1991
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991